Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
03/2003
03/26/2003EP1198226B1 Mesalazine controlled release oral pharmaceutical compositions
03/26/2003EP1181010A4 Pharmaceutical chewing gum formulations
03/26/2003EP1173215A4 Over-coated chewing gum formulations
03/26/2003EP1156786B1 Orally dispersible tablet with low friability and method for preparing same
03/26/2003EP1140960A4 Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
03/26/2003EP1140195B1 Oil-in-water emulsion exhibiting a protective action against damages to human organs resulting from peroxidation, and the production and use thereof
03/26/2003EP1128725B1 Disposable premoistened wipe containing an antimicrobial protease inhibitor
03/26/2003EP1126848B1 Plastics container containing stabilised drug formulations
03/26/2003EP1098631B1 Pharmaceutical composition in particular for preventing and treating mucositis induced by radiotherapy or chemotherapy
03/26/2003EP1087735B1 Adhesively applied external nasal strips and dilators containing medications and fragrances
03/26/2003EP1077703B1 Oral medicinal preparations with reproducible release of the active ingredient gatifloxacin or its pharmaceutically suitable salts or hydrates
03/26/2003EP1075263B1 Aqueous process for manufacturing paroxetine solid dispersions
03/26/2003EP1049458B1 Lyophilization method for sustained-release preparations
03/26/2003EP1049452B1 Reduced lipid flowable cosmetic or dermatological preparations
03/26/2003EP1042339B1 Carbohydrates, useful in solid delivery systems
03/26/2003EP1041969B1 Novel pharmaceutical compositions of uridine triphosphate
03/26/2003EP1032373B1 Drug delivery systems utilizing liquid crystal structures
03/26/2003EP0941070B1 Lozenge for the modified releasing of active substances in the gastrointestinal tract
03/26/2003EP0877599B1 Sustained delivery of leuprolide using an implantable system
03/26/2003EP0848621B1 Wound treatment composition
03/26/2003EP0831867B1 Collagen-based delivery matrix
03/26/2003EP0806941B1 Low rigidity liposomal antibacterial composition
03/26/2003EP0772436B1 Incorporation of biologically active molecules into bioactive glasses
03/26/2003EP0766514B1 Flash flow formed solloid delivery systems
03/26/2003EP0740528B1 Gas microspheres for topical and subcutaneous application
03/26/2003EP0670716B1 Tastemasked pharmaceutical materials
03/26/2003EP0431135B1 Particle-mediated transformation of animal somatic cells
03/26/2003CN2540956Y Medicinal plaster for meridian and acupoint
03/26/2003CN1406276A Sericin-containing material, Process for producing the same and method of using the same
03/26/2003CN1406238A A novel crystalline form of N-[4-[2-(2-amino-4,7-dihydro-4-oxo-3H-pyrrolo [2,3-d] pyrimidin-5-yl) ethyl] benzoyl]-L-glutamic acid and process therefor
03/26/2003CN1406140A Nano capsule encapsulation system and method
03/26/2003CN1406130A Veterinary compositions for the treatment of parasitic diseases
03/26/2003CN1406126A New sustained release oral formulations
03/26/2003CN1406125A Method for transdermal or intradermal delivery of molecules
03/26/2003CN1406124A Nasally administrable cyclic peptide compositions
03/26/2003CN1406112A Composition for intestinal delivery
03/26/2003CN1405314A Cryptoporus volvatus fermented product, and its preparation method and application
03/26/2003CN1404871A Chinese medicinal plaster for treatment of bone-fracture
03/26/2003CN1404864A Chinese medicine for treatment of depression
03/26/2003CN1404858A Shaoshangling-medicine for treating fire burn
03/26/2003CN1404851A Medicine for treating kidney disease
03/26/2003CN1404849A Plaster medicine for giving up smoking
03/26/2003CN1404839A Notoginseng total saponin oral liquor
03/26/2003CN1404833A 药物组合物 The pharmaceutical composition of
03/26/2003CN1404832A Gliclazide oral tablet capable of quickly disintegrating and dissolving out and its preparation technology
03/26/2003CN1404830A Method for preparing controllable complex of taxiol and polylactic acid
03/26/2003CN1404827A 硫普罗宁制剂 Tiopronin preparations
03/26/2003CN1404826A Method for preparing naproxen sodium release tablet
03/26/2003CN1404823A Gastrodia-tuer powder injection
03/26/2003CN1103643C Film coatings and film coating compositions based on dextrin
03/26/2003CN1103628C Application of extrusion device
03/26/2003CN1103605C Administrable compositions and method for magnetic resonance imaging
03/26/2003CN1103604C Iron-containing nano particles with double coating and their use in diagnosis and therapy
03/26/2003CN1103602C Process for preparing pharmaceutical formulation containing insulin analog
03/26/2003CN1103601C Release-controlled somatotropin composition and method for preparation thereof
03/26/2003CN1103599C Medicinal composition for treating asthma and its preparation method
03/26/2003CN1103589C Method for modulating human sexual response
03/26/2003CN1103587C Compressible enzyme powder
03/26/2003CN1103586C Sucrose ester C20-28 alcohol formulations
03/26/2003CN1103548C Edible micro-capsule and food containing same
03/26/2003CA2405378A1 Stable taurolidine electrolyte solutions
03/25/2003US6538155 Cleaning compounds for animal ears
03/25/2003US6538039 Pharmaceutical dosage form for transdermal administration
03/25/2003US6538035 And treatment of Chronic Obstructive Pulmonary Disease and allergic rhinitis
03/25/2003US6538030 Treating radiation fibrosis
03/25/2003US6538020 Paclitaxel formulation
03/25/2003US6538019 Produce emulsions containing a material that are insoluble or that have low solubility with respect to water and oil in a high concentration, so as to obtain emulsions which can be preserved for a long period of time. More specifically,
03/25/2003US6537985 Antibiotic formulation and a method of making this formulation
03/25/2003US6537983 Anti-inflammatory androstane derivatives
03/25/2003US6537979 Water-insoluble derivatives of hyaluronic acid crosslinked with a biscarbodiimide
03/25/2003US6537970 The invention relates to a novel pharmaceutical combination comprising clindamycin and clotrimazole for use for vaginal infections.
03/25/2003US6537968 Treatment of an individual suffering from lupus erythematosus utilizing a serine protease inhibitor. The treatment includes the use of a corticosteroid that is administered separately or in combination. The serine proteases preferred are alpha
03/25/2003US6537933 Silk cloths for protecting affected parts
03/25/2003US6537814 Compositions and methods for altering the biodistribution of biological agents
03/25/2003US6537586 Apparatus and method for preparing microparticles
03/25/2003US6537585 Methods and compositions for treating solid tumors
03/25/2003US6537584 Polymer blends that swell in an acidic environment and deswell in a basic environment
03/25/2003US6537583 Method for preparing capsules consisting of a liquid active material core enclosed in a mineral coating
03/25/2003US6537582 Anti-inflammatory pharmaceutical formulations
03/25/2003US6537580 Stable shaped particles of crystalline organic compounds
03/25/2003US6537579 Compositions and methods for administration of pharmacologically active compounds
03/25/2003US6537578 Once-a-day controlled release sulfonylurea formulation
03/25/2003US6537577 Method of prophylaxis for bovine mastitis
03/25/2003US6537576 Biologically active composition
03/25/2003US6537575 Synthetic biological membrane with self organizing properties
03/25/2003US6537573 Combination dosage form comprising cetirizine and pseudoephedrine
03/25/2003US6537572 Patch type aluminum remedial implement
03/25/2003US6537571 Transdermal therapeutic system containing the active substance scopolamine base
03/25/2003US6537569 Radiation cross-linked hydrogels
03/25/2003US6537568 Releasing therapic dosage to tissues
03/25/2003US6537566 Compositions and methods for the non-invasive treatment of uterine fibroid cells
03/25/2003US6537561 Fat emulsion for oral administration
03/25/2003US6537545 Use of corneal hardening agents in enzymeorthokeratology
03/25/2003US6537538 Polystyrene sulfonate inhibits Trichomonas, Gardnerella, and other vaginitis/vaginosis-causing bacteria
03/25/2003US6537525 Medicated chewing-gum
03/25/2003US6537524 Inflammatory or obstructive airways disease
03/25/2003US6537268 Medical infusion device with a source of controlled compliance
03/25/2003US6537256 Microfabricated devices for the delivery of molecules into a carrier fluid
03/25/2003US6537250 Fluid delivery device with electrically activated energy source
03/25/2003US6537246 Oxygen delivery agents and uses for the same
1 ... 2163 2164 2165 2166 2167 2168 2169 2170 2171 2172 2173 2174 2175 2176 2177 2178 2179 2180 2181 2182 2183 ... 2991